Bushnell, G., Lloyd, K., Olfson, M., Gerhard, T., Keyes, K., Cerdá, M., & Hasin, D. (2025). Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001–2019. Addiction. Portico. https://doi.org/10.1111/add.16749

Garritsen, H. H., Khan, F., Rozema, A. D., Navas‐Acien, A., & Hernández, D. (2024). Associations of smoke‐free policies in multi‐unit housing with smoking behavior and second‐hand smoke exposure: A systematic review. Addiction. Portico. https://doi.org/10.1111/add.16724

Borodovsky, J. T., Hasin, D. S., Wall, M., Struble, C. A., Habib, M. I., Livne, O., Liu, J., Chen, L., Aharonovich, E., & Budney, A. J. (2024). Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction. Portico. https://doi.org/10.1111/add.16700

Hayes, C. J., Raciborski, R. A., Nowak, M., Acharya, M., Nunes, E. V., & Winhusen, T. J. (2024). Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type. Addiction. Portico. https://doi.org/10.1111/add.16659

Berridge, V., Hall, W., Morphett, K., Fairchild, A., Bayer, R., & Gartner, C. (2024). Evidence and policy is certainly more complex than it seems. Addiction. Portico. https://doi.org/10.1111/add.16660

Ross, R. K., Rudolph, K. E., & Shover, C. L. (2024). Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022. Addiction. Portico. https://doi.org/10.1111/add.16652

Ross, R. K., Nunes, E. V., Olfson, M., Shulman, M., Krawczyk, N., Stuart, E. A., & Rudolph, K. E. (2024). Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Addiction. Portico. https://doi.org/10.1111/add.16630

Yimsaard, P., Mootz, J. J., Rungnirundorn, T., Janamnuaysook, R., Samitpol, K., Phanuphak, N., & Wainberg, M. L. (2024). Assessing the acceptability of implementing a Screening, Brief Intervention and Referral to Treatment for alcohol use among transgender women in Bangkok, Thailand: A mixed‐method pre‐implementation study using the Consolidated Framework for Implementation Research. Addiction, 119(5), 863–874. Portico. https://doi.org/10.1111/add.16423

Brandt, L., Odom, G. J., Hu, M., Castro, C., & Balise, R. R. (2024). Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions. Addiction, 119(7), 1289–1300. Portico. https://doi.org/10.1111/add.16494

Berridge, V., Fairchild, A. L., Morphett, K., Gartner, C., Hall, W., & Bayer, R. (2024). E‐cigarettes: A framework for comparative history and policy. Addiction. Portico. https://doi.org/10.1111/add.16462

Foot, C., Korthuis, P. T., Tsui, J. I., Luo, S. X., Chan, B., & Cook, R. R. (2023). Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder. Addiction, 119(1), 149–157. Portico. https://doi.org/10.1111/add.16334

Keyes, K. M., & Patrick, M. E. (2023). Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021. Addiction, 118(12), 2449–2454. Portico. https://doi.org/10.1111/add.16259

Shulman, M., Greiner, M., & Bisaga, A. (2023). Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder. Addiction, 119(1), 158–159. Portico. https://doi.org/10.1111/add.16374

Bushnell, G. A., Rynn, M. A., Gerhard, T., Keyes, K. M., Hasin, D. S., Cerdá, M., Nyandege, A., & Olfson, M. (2023). Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction, 119(2), 356–368. Portico. https://doi.org/10.1111/add.16359

Adams, R. S., McKetta, S. C., Jager, J., Stewart, M. T., & Keyes, K. M. (2023). Cohort effects of women’s mid‐life binge drinking and alcohol use disorder symptoms in the United States: Impacts of changes in timing of parenthood. Addiction, 118(10), 1932–1941. Portico. https://doi.org/10.1111/add.16262

Kianersi, S., Ludema, C., Agley, J., Ahn, Y., Parker, M., Ideker, S., & Rosenberg, M. (2023). Development and validation of a model for measuring alcohol consumption from transdermal alcohol content data among college students. Addiction, 118(10), 2014–2025. Portico. https://doi.org/10.1111/add.16228

Markham, F., Gobaud, A. N., Mehranbod, C. A., & Morrison, C. N. (2023). Casino accessibility and suicide: A county‐level study of 50 US states, 2000 to 2016. Addiction, 118(7), 1351–1358. Portico. https://doi.org/10.1111/add.16153

Jangard, S., Jayaram‐Lindström, N., Isacsson, N. H., Matheson, G. J., Plavén‐Sigray, P., Franck, J., Borg, J., Farde, L., & Cervenka, S. (2023). Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers. Addiction, 118(6), 1053–1061. Portico. https://doi.org/10.1111/add.16144

Fink, D. S., Keyes, K. M., Branas, C., Cerdá, M., Gruenwald, P., & Hasin, D. (2023). Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties. Addiction, 118(6), 1072–1082. Portico. https://doi.org/10.1111/add.16123

Verdejo‐Garcia, A., Rezapour, T., Giddens, E., Khojasteh Zonoozi, A., Rafei, P., Berry, J., Caracuel, A., Copersino, M. L., Field, M., Garland, E. L., Lorenzetti, V., Malloy‐Diniz, L., Manning, V., Marceau, E. M., Pennington, D. L., Strickland, J. C., Wiers, R., Fairhead, R., Anderson, A., … Ekhtiari, H. (2022). Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study. Addiction, 118(5), 935–951. Portico. https://doi.org/10.1111/add.16109

Krawczyk, N., Rivera, B. D., Basaraba, C., Corbeil, T., Allen, B., Schultebraucks, K., Henry, B. F., Pincus, H. A., Levin, F. R., & Martinez, D. (2023). COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Addiction, 118(5), 857–869. Portico. https://doi.org/10.1111/add.16105

Luba, R., Jones, J., Choi, C. J., & Comer, S. (2022). Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance. Addiction, 118(4), 719–726. Portico. https://doi.org/10.1111/add.16100

Suri, A., Feaster, D. J., Balise, R. R., Quinn, J., Nunes, E. V., Gilbert, L., El‐Bassel, N., & Rundle, A. G. (2022). Impacts of the New York State COVID‐19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder. Addiction, 118(4), 711–718. Portico. https://doi.org/10.1111/add.16087

Greene, M. C. (2022). Commentary on Saleh et al: The triple burden of stigma experienced by forcibly displaced people with substance use disorder ‐ considerations for research and practice. Addiction, 118(2), 254–255. Portico. https://doi.org/10.1111/add.16094

Livne, O., Shmulewitz, D., Walsh, C., & Hasin, D. S. (2022). Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP. Addiction, 117(12), 3099–3109. Portico. https://doi.org/10.1111/add.15987

Williams, A. R. (2022). Commentary on Burns et al: MOUD saves lives, especially after 60 days, and the longer the better. Addiction, 117(12), 3089–3090. Portico. https://doi.org/10.1111/add.16043

Rivera‐Aguirre, A., Castillo‐Carniglia, A., Laqueur, H. S., Rudolph, K. E., Martins, S. S., Ramírez, J., Queirolo, R., & Cerdá, M. (2022). Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay. Addiction, 117(11), 2866–2877. Portico. https://doi.org/10.1111/add.15913

Morrison, C. N. (2022). Commentary on Gruenewald et al.: ‘Even one more license may be “too many”’? Addiction, 117(10), 2623–2624. Portico. https://doi.org/10.1111/add.15979

Karnik, N. S., Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y., McHugh, R. K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli‐Blumberg, D., Shulman, M., … Wu, L. (2022). The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study. Addiction, 117(9), 2438–2447. Portico. https://doi.org/10.1111/add.15875

Keyes, K. M., Kreski, N. T., Ankrum, H., Cerdá, M., Chen, Q., Hasin, D. S., Martins, S. S., Olfson, M., & Miech, R. (2022). Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19. Addiction, 117(8), 2316–2324. Portico. https://doi.org/10.1111/add.15912

Weinberger, A. H., Wyka, K., Kim, J. H., Smart, R., Mangold, M., Schanzer, E., Wu, M., & Goodwin, R. D. (2022). A difference‐in‐difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004–17. Addiction, 117(6), 1768–1777. Portico. https://doi.org/10.1111/add.15795

Nesoff, E. D., Marziali, M. E., & Martins, S. S. (2021). The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic. Addiction, 117(6), 1781–1786. Portico. https://doi.org/10.1111/add.15778

Morrison, C. N., Kwizera, M., Chen, Q., Puljevic, C., Branas, C. C., Wiebe, D. J., Peek‐Asa, C., McGavin, K. M., Franssen, S. J., Le, V. K., Keating, M., & Ferris, J. (2022). The geography of sobriety checkpoints and alcohol‐impaired driving. Addiction, 117(5), 1450–1457. Portico. https://doi.org/10.1111/add.15766

Philbin, M. M., Giovenco, D. P., & Mauro, P. M. (2022). Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co‐use ‐ research and measurement implications to move the field forward. Addiction, 117(6), 1778–1780. Portico. https://doi.org/10.1111/add.15885

Rudolph, K. E., Shulman, M., Fishman, M., Díaz, I., Rotrosen, J., & Nunes, E. V. (2021). Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse. Addiction, 117(3), 637–645. Portico. https://doi.org/10.1111/add.15654

Nordeck, C. D., Riehm, K. E., Smail, E. J., Holingue, C., Kane, J. C., Johnson, R. M., Veldhuis, C. B., Kalb, L. G., Stuart, E. A., Kreuter, F., & Thrul, J. (2021). Changes in drinking days among United States adults during the COVID‐19 pandemic. Addiction, 117(2), 331–340. Portico. https://doi.org/10.1111/add.15622